Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report

Artif Organs. 1988 Dec;12(6):484-90. doi: 10.1111/j.1525-1594.1988.tb02809.x.

Abstract

Nine homosexual patients with immune thrombocytopenia were treated with autologous plasma that had been perfused over silica-immobilized Staphylococcus aureus protein A (SpA). Pretreatment platelet counts ranged from 10,000 to 98,000 cells/mm3 (mean: 54,000 cells/mm3). Six patients responded to therapy. Platelets increased by a mean of 95,000 cells/mm3 (p less than 0.007) and reached normal levels (greater than 150,000 cells/mm3) in four patients. Increased platelet counts are presently sustained in these four individuals after 5 months of follow-up. Increases in platelet counts significantly correlated with decreases in platelet-associated IgG (PAIgG), platelet-directed IgG (PDIgG), and immune complexes (CIC). PAIgG and PDIgG declined by a mean of 67% (p less than 0.003) and 58% (p less than 0.007), respectively. CIC decreased by a mean of 37% (p = 0.02). Complement was concomitantly activated in all four examined patients. C3a and C5a increased 23-fold and 2.6-fold, respectively, while total hemolytic complement decreased by 50%. Activated complement components and removal of CIC and IgG thus may contribute to the platelet-enhancing activity of SpA immunoadsorption therapy.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Antigen-Antibody Complex / analysis
  • Blood Transfusion, Autologous
  • Complement Activation
  • Humans
  • Immunoglobulin G / analysis
  • Immunosorbent Techniques
  • Immunotherapy / methods*
  • Male
  • Middle Aged
  • Platelet Count
  • Purpura, Thrombocytopenic / etiology
  • Purpura, Thrombocytopenic / therapy*
  • Staphylococcal Protein A*

Substances

  • Antigen-Antibody Complex
  • Immunoglobulin G
  • Staphylococcal Protein A